Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 4013639, 10 pages
http://dx.doi.org/10.1155/2016/4013639
Review Article

Role of Vanadium in Cellular and Molecular Immunology: Association with Immune-Related Inflammation and Pharmacotoxicology Mechanisms

1Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
2Laboratory of Clinical and Molecular Endocrinology, 1st Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
3Department of Medicine, Laboratory of General Biology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
4Department of Medicine, Laboratory of Forensic Medicine and Toxicology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
5Forensic Medical Service of Thessaloniki, Ministry of Justice, Transparency, and Human Rights, Dimokratias 1 Square, 54012 Thessaloniki, Greece

Received 31 December 2015; Accepted 13 March 2016

Academic Editor: Juan Llopis

Copyright © 2016 Olga Tsave et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. D. Mjos and C. Orvig, “Metallodrugs in medicinal inorganic chemistry,” Chemical Reviews, vol. 114, no. 8, pp. 4540–4563, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. J. J. Soldevila-Barreda and P. J. Sadler, “Approaches to the design of catalytic metallodrugs,” Current Opinion in Chemical Biology, vol. 25, pp. 172–183, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Spreckelmeyer, C. Orvig, and A. Casini, “Cellular transport mechanisms of cytotoxic metallodrugs: an overview beyond cisplatin,” Molecules, vol. 19, no. 10, pp. 15584–15610, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Rehder, “Vanadium. Its role for humans,” Metal Ions in Life Sciences, vol. 13, pp. 139–169, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. E. V. Fedorova, A. V. Buryakina, N. M. Vorobieva, and N. I. Baranova, “The vanadium compounds: chemistry, synthesis, insulinomimetic properties,” Biomeditsinskaya Khimiya, vol. 60, no. 4, pp. 416–429, 2014. View at Publisher · View at Google Scholar
  6. J. Korbecki, I. Baranowska-Bosiacka, I. Gutowska, and D. Chlubek, “Biochemical and medical importance of vanadium compounds,” Acta Biochimica Polonica, vol. 59, no. 2, pp. 195–200, 2012. View at Google Scholar · View at Scopus
  7. E. Kioseoglou, S. Petanidis, C. Gabriel, and A. Salifoglou, “The chemistry and biology of vanadium compounds in cancer therapeutics,” Coordination Chemistry Reviews, vol. 301-302, pp. 87–105, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Imtiaz, M. S. Rizwan, S. Xiong et al., “Vanadium, recent advancements and research prospects: a review,” Environment International, vol. 80, pp. 79–88, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Mukherjee, B. Patra, S. Mahapatra, P. Banerjee, A. Tiwari, and M. Chatterjee, “Vanadium—an element of atypical biological significance,” Toxicology Letters, vol. 150, no. 2, pp. 135–143, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Rehder, J. Costa Pessoa, C. F. G. C. Geraldes et al., “In vitro study of the insulin-mimetic behaviour of vanadium(IV, V) coordination compounds,” Journal of Biological Inorganic Chemistry, vol. 7, no. 4-5, pp. 384–396, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Gabriel, J. Venetis, M. Kaliva et al., “Probing for missing links in the binary and ternary V(V)-citrate-(H2O2) systems: synthetic efforts and in vitro insulin mimetic activity studies,” Journal of Inorganic Biochemistry, vol. 103, no. 4, pp. 503–516, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. D. C. Crans, J. J. Smee, E. Gaidamauskas, and L. Yang, “The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds,” Chemical Reviews, vol. 104, no. 2, pp. 849–902, 2004. View at Publisher · View at Google Scholar
  13. I. Zwolak, “Vanadium carcinogenic, immunotoxic and neurotoxic effects: a review of in vitro studies,” Toxicology Mechanisms and Methods, vol. 24, no. 1, pp. 1–12, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Valko, H. Morris, and M. T. D. Cronin, “Metals, toxicity and oxidative stress,” Current Medicinal Chemistry, vol. 12, no. 10, pp. 1161–1208, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Ha, H. Joo, G. Ahn et al., “Jeju ground water containing vanadium induced immune activation on splenocytes of low dose γ-rays-irradiated mice,” Food and Chemical Toxicology, vol. 50, no. 6, pp. 2097–2105, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Ramanadham and M. Kern, “Differential effect of vanadate on DNA synthesis induced by mitogens in T and B lymphocytes,” Molecular and Cellular Biochemistry, vol. 51, no. 1, pp. 67–71, 1983. View at Publisher · View at Google Scholar · View at Scopus
  17. J. J. Mongold, G. H. Cros, L. Vian et al., “Toxicological aspects of vanadyl sulphate on diabetic rats: effects on vanadium levels and pancreatic B-cell morphology,” Pharmacology and Toxicology, vol. 67, no. 3, pp. 192–198, 1990. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Malissen, C. Grégoire, M. Malissen, and R. Roncagalli, “Integrative biology of T cell activation,” Nature Immunology, vol. 15, no. 9, pp. 790–797, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Cui, H. Cui, X. Peng et al., “Excess dietary vanadium induces the changes of subsets and proliferation of splenic T cells in broilers,” Biological Trace Element Research, vol. 143, no. 2, pp. 932–938, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Wang, H. Cui, Y. Deng et al., “Effect of dietary vanadium on the ileac T cells and contents of cytokines in broilers,” Biological Trace Element Research, vol. 147, no. 1–3, pp. 113–119, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Ustarroz-Cano, I. García-Peláez, G. Piñón-Zárate, M. Herrera-Enríquez, G. Soldevila, and T. I. Fortoul, “CD11c decrease in mouse thymic dendritic cells after vanadium inhalation,” Journal of Immunotoxicology, vol. 9, no. 4, pp. 374–380, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Lee, X. Shen, and R. König, “Effects of cadmium and vanadium ions on antigen-induced signaling in CD4+ T cells,” Toxicology, vol. 169, no. 1, pp. 53–65, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Anestakis, S. Petanidis, S. Kalyvas et al., “Mechanisms and applications of interleukins in cancer immunotherapy,” International Journal of Molecular Sciences, vol. 16, no. 1, pp. 1691–1710, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. J. L. Stow and R. Z. Murray, “Intracellular trafficking and secretion of inflammatory cytokines,” Cytokine and Growth Factor Reviews, vol. 24, no. 3, pp. 227–239, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Gallardo-Vera, D. Diaz, M. Tapia-Rodriguez et al., “Vanadium pentoxide prevents NK-92MI cell proliferation and IFN-γ secretion through sustained JAK3 phosphorylation,” Journal of Immunotoxicology, vol. 13, no. 1, pp. 27–37, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Cui, H.-M. Cui, X. Peng, Z. Zuo, X. Liu, and B. Wu, “Effect of vanadium on the subset and proliferation of peripheral blood T cells, and serum interleukin-2 content in broilers,” Biological Trace Element Research, vol. 141, no. 1–3, pp. 192–199, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. D. Cohen, E. Parsons, R. B. Schlesinger, and J. T. Zelikoff, “Immunotoxicity of in vitro vanadium exposures: effects on interleukin-1, tumor necrosis factor-α, and prostaglandin E2 production by WEHI-3 macrophages,” International Journal of Immunopharmacology, vol. 15, no. 3, pp. 437–446, 1993. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Srivastava, N. Kumar, and P. Roy, “Role of ERK/NF-κB in vanadium (IV) oxide mediated osteoblast differentiation in C3H10t1/2 cells,” Biochimie, vol. 101, no. 1, pp. 132–144, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Castaldi, C. Serra, F. Moretti et al., “Bisperoxovanadium, a phospho-tyrosine phosphatase inhibitor, reprograms myogenic cells to acquire a pluripotent, circulating phenotype,” The FASEB Journal, vol. 21, no. 13, pp. 3573–3583, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Chen, L. M. Demers, V. Vallyathan et al., “Vanadate induction of NF-κB involves IκB kinase β and SAPK/ERK kinase 1 in macrophages,” The Journal of Biological Chemistry, vol. 274, no. 29, pp. 20307–20312, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Imbert, R. A. Rupec, A. Livolsi et al., “Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α,” Cell, vol. 86, no. 5, pp. 787–798, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. M. J. Jiménez-Dalmaroni, M. E. Gerswhin, and I. E. Adamopoulos, “The critical role of toll-like receptors—from microbial recognition to autoimmunity: a comprehensive review,” Autoimmunity Reviews, vol. 15, no. 1, pp. 1–8, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Deng, S. Zhu, Y. Qiao et al., “Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma,” Protein and Cell, vol. 5, no. 12, pp. 899–911, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. S. H. Aalaei-Andabili, M. Fabbri, and N. Rezaei, “Reciprocal effects of Toll-like receptors and miRNAs on biological processes in human health and disease: a systematic review,” Immunotherapy, vol. 5, no. 10, pp. 1127–1142, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Olivares-Navarrete, S. L. Hyzy, P. J. Slosar, J. M. Schneider, Z. Schwartz, and B. D. Boyan, “Implant materials generate different peri-implant inflammatory factors: PEEK promotes fibrosis and Micro-textured titanium promotes osteogenic factors,” Spine, vol. 40, no. 6, pp. 399–404, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Kay, R. S. Scotland, and J. R. Whiteford, “Toll-like receptors: role in inflammation and therapeutic potential,” BioFactors, vol. 40, no. 3, pp. 284–294, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Muralidharan and P. Mandrekar, “Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation,” Journal of Leukocyte Biology, vol. 94, no. 6, pp. 1167–1184, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Divekar and H. Kita, “Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation,” Current Opinion in Allergy and Clinical Immunology, vol. 15, no. 1, pp. 98–103, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Fietta, E. Costa, and G. Delsante, “Interleukins (ILs), a fascinating family of cytokines. Part I: ILs from IL-1 to IL-19,” Theoretical biology forum, vol. 107, no. 1-2, pp. 13–45, 2014. View at Google Scholar · View at Scopus
  40. A. Basu, S. Singha Roy, A. Bhattacharjee et al., “Vanadium(III)-L-cysteine protects cisplatin-induced nephropathy through activation of Nrf2/HO-1 pathway,” Free Radical Research, vol. 50, no. 1, pp. 39–55, 2015. View at Publisher · View at Google Scholar
  41. L.-L. Mao, D.-L. Hao, X.-W. Mao et al., “Neuroprotective effects of bisperoxovanadium on cerebral ischemia by inflammation inhibition,” Neuroscience Letters, vol. 602, pp. 120–125, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. J. C. Pessoa, S. Etcheverry, and D. Gambino, “Vanadium compounds in medicine,” Coordination Chemistry Reviews, vol. 301-302, pp. 24–48, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. J. C. Pessoa, E. Garribba, M. F. A. Santos, and T. Santos-Silva, “Vanadium and proteins: uptake, transport, structure, activity and function,” Coordination Chemistry Reviews, vol. 301-302, pp. 49–86, 2015. View at Publisher · View at Google Scholar · View at Scopus